title: Interferon-induced anti-HBE seroconversion correlates with a Th1 cytokine shift following emergence of core promoter mutations in chronic hepatitis B.
authors.forename: Rosa
authors.initials: R
authors.lastname: Zampino
authors.forename: Emanuele
authors.initials: E
authors.lastname: Durante Mangoni
authors.forename: Aldo
authors.initials: A
authors.lastname: Marrone
authors.forename: Riccardo
authors.initials: R
authors.lastname: Utili
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Ruggiero
authors.forename: Luigi Elio
authors.initials: LE
authors.lastname: Adinolfi
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D016207:Cytokines / Q000097:blood*; D005500:Follow-Up Studies; D006513:Hepatitis B e Antigens / Q000097:blood*; D006515:Hepatitis B virus / Q000235:genetics*; D019694:Hepatitis B, Chronic / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D009154:Mutation / Q000235:genetics*; D011401:Promoter Regions, Genetic / Q000235:genetics*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D016207:Cytokines; D006513:Hepatitis B e Antigens; D016898:Interferon-alpha